Saratoga Investment Corp. (SAR) · Oct 9, 2026 · New debt
$25M facility increase — Valley facility raised from $85M to $110M
Saratoga Investment’s credit facility amendment adds $25 million of borrowing capacity and broadens portfolio flexibility, but also raises concentration risk.
Saratoga is a business development company financing private U.S. middle-market businesses through senior, unitranche and mezzanine loans; its operating story is about scaling the loan portfolio while preserving borrowing capacity and credit protections.
The headline change is meaningfully more funding capacity. The amendment increases the Valley warehouse facility from $85 million to $110 million, a $25 million or roughly 29% increase in committed capacity. That gives Saratoga more room to originate or acquire loans without immediately needing another external financing, although the filing does not say how much of the new capacity will be drawn.
The amendment also makes the facility more usable for portfolio growth. The two-year expansion option rises from $100 million to $135 million, while the permitted healthcare concentration increases from 25% to 35% and the top-three-obligor limit rises from 30% to 35%. 〔0〕 These are practical loosening measures: Saratoga can deploy capital into larger individual exposures and more healthcare lending, rather than being forced to diversify as aggressively.
The trade-off is a tighter borrowing rule for unitranche loans. The amendment explicitly caps their advance rate at 70%, meaning Saratoga may need to fund more equity against those assets than before or receive less financing credit for them. 〔1〕 The filing does not quantify the impact on current borrowing capacity, so this is a constraint on asset-level leverage rather than evidence of an immediate problem.
This is a financing-enablement event, not a change in the investment thesis. It supports Saratoga’s existing middle-market lending strategy and appears to have been completed without a waiver or distress signal; the amendment documents state that no Default, Event of Default or Ratings Deficiency was continuing. 〔2〕 The replacement of Henri Steenkamp with Christine Ramdihal as a “Key Person” is administrative in this filing and is not presented as a broader management disruption. 〔3〕
Bottom line: Saratoga has secured a larger and more flexible borrowing platform for expanding its private-credit portfolio. The signal is modestly constructive, but the higher concentration allowances and 70% unitranche advance cap mean this is better viewed as added capacity with revised guardrails, not unrestricted leverage.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!